loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of Drug Master Files (DMF) for 25421 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Fareva (1)

filter

01 DEFEROXAMINE MESYLATE USP (1)

filter

01 Luxembourg (1)

filter

01 Active (1)

filter

01 Complete (1)

Looking for Drug Master Files (DMF) for 25421 of Excella Gmbh And Co Kg

Looking for Drug Master Files (DMF) for 25421 of Excella Gmbh And Co Kg 1

20

Excella Gmbh And Co Kg, based in Luxembourg, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

One of their notable products is DEFEROXAMINE MESYLATE USP, with a corresponding US DMF Number 25421.

Remarkably, this DMF maintains an Active status since its submission on March 01, 2012, highlighting commitment to regulatory compliance.

Their GDUFA DMF Review was successfully complete, with a review date of June 25, 2013, and payment made on January 15, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II

Post Enquiry
POST ENQUIRY